In situ delivery of allogeneic natural killer cell (NK) combined with Cetuximab in liver metastases of gastrointestinal carcinoma: A phase I clinical trial.
Electrochemotherapy combined with immunotherapy - a promising potential in the treatment of cancer.
Hadzialjevic B, Omerzel M, Trotovsek B, Cemazar M, Jesenko T, Sersa G, Djokic M.
Front Immunol. 2024 Jan 15;14:1336866. doi: 10.3389/fimmu.2023.1336866. eCollection 2023.
In situ delivery of allogeneic natural killer cell (NK) combined with Cetuximab in liver metastases of gastrointestinal carcinoma: A phase I clinical trial.
Adotevi O, Godet Y, Galaine J, Lakkis Z, Idirene I, Certoux JM, Jary M, Loyon R, Laheurte C, Kim S, Dormoy A, Pouthier F, Barisien C, Fein F, Tiberghien P, Pivot X, Valmary-Degano S, Ferrand C, Morel P, Delabrousse E, Borg C.
Oncoimmunology. 2018 Mar 19;7(5):e1424673. doi: 10.1080/2162402X.2018.1424673. eCollection 2018.
In Situ Nanoparticle Self-Assembly for Combination Delivery of Therapeutics to Non-Small Cell Lung Cancer.
Hatami E, Nagesh PKB, Chauhan N, Jaggi M, Chauhan SC, Yallapu MM.
ACS Appl Bio Mater. 2022 Mar 21;5(3):1104-1119. doi: 10.1021/acsabm.1c01158. Epub 2022 Feb 18.
Intra-arterial interleukin-12 gene delivery combined with chemoembolization: anti-tumor effect in a rabbit hepatocellular carcinoma (HCC) model.
Xia X, Li X, Feng G, Zheng C, Liang H, Zhou G.
Acta Radiol. 2013 Jul;54(6):684-9. doi: 10.1177/0284185113480072. Epub 2013 Apr 30.
Panobinostat Induced Spatial In Situ Biomarkers Predictive of Anti-PD-1 Efficacy in Mouse Mammary Carcinoma.
Tatarova Z, Blumberg DC, Bensen A, Mills GB, Jonas O.
Cells. 2023 Jan 13;12(2):308. doi: 10.3390/cells12020308.
In-situ-formed immunotherapeutic and hemostatic dual drug-loaded nanohydrogel for preventing postoperative recurrence of hepatocellular carcinoma.
Ke J, Liu Y, Liu F, Cai H, Li X, Zhang Z, Wang N, Shao B, Wang Z, Han M, Ji B.
J Control Release. 2024 Aug;372:141-154. doi: 10.1016/j.jconrel.2024.06.030. Epub 2024 Jun 18.
Engineering nanotheranostic strategies for liver cancer.
Cao L, Zhu YQ, Wu ZX, Wang GX, Cheng HW.
World J Gastrointest Oncol. 2021 Oct 15;13(10):1213-1228. doi: 10.4251/wjgo.v13.i10.1213.
Development of in situ forming thermosensitive hydrogel for radiotherapy combined with chemotherapy in a mouse model of hepatocellular carcinoma.
Peng CL, Shih YH, Liang KS, Chiang PF, Yeh CH, Tang IC, Yao CJ, Lee SY, Luo TY, Shieh MJ.
Mol Pharm. 2013 May 6;10(5):1854-64. doi: 10.1021/mp3006424. Epub 2013 Apr 1.
Precise In Situ Delivery of a Photo-enhanceable Inflammasome-Activating Nanovaccine Activates Anti-cancer Immunity.
Zhou Y, Pang L, Ding T, Chen K, Liu J, Wu M, Wang W, Man K.
Cancer Res. 2024 Sep 17. doi: 10.1158/0008-5472.CAN-24-0220. Online ahead of print.
Pre-activated nanoparticles with persistent luminescence for deep tumor photodynamic therapy in gallbladder cancer.
Juengpanich S, Li S, Yang T, Xie T, Chen J, Shan Y, Lee J, Lu Z, Chen T, Zhang B, Cao J, Hu J, Yu J, Wang Y, Topatana W, Gu Z, Cai X, Chen M.
Nat Commun. 2023 Sep 14;14(1):5699. doi: 10.1038/s41467-023-41389-1.
